Canopus Bioscience Leading the Way for Cancer Diagnostics

Canopus develops instrumentation and methodologies that are focused on the goal of  
improving patient-specific diagnostics and disease management.

News:  First Quarter of 2012

As part of our objective to create a strong presence in Europe we are planning 
a clinical study that will take place at a prestigious French Institution. 

Canopus is also entering into a joint project to design precision low cost
microfiltration/fluidic  devices. This project will be utilizing leading edge manufacturing
technology and will allow  the production of these micro devices to be scaled up to
very large volumes.


Les nouvelles en bref du premier trimestre 2012

Dans le cadre de notre objectif d'avoir une forte présence en Europe, nous prévoyons 
de commencer une étude clinique en partenariat avec un établissement français
de renommée mondiale.

Canopus a conclu un projet de coopération pour concevoir un nouveau système de

microfiltration de très grande précision à un prix de revient très abordable. Ce projet
fera appel à une technologie de pointe permettant la fabrication en grandes séries. 

Past News

Our superior enrichment technology is now protected by key patents
2010 US Patent #7,695,966  (granted)
Method for the separation and sorting of different biological objects utilizing
differences in their viscoelastic properties

2008 PCT/EP2008/057826 (filed)
Our prototype based on the patent has a sample throughput of up to 12 samples per
hour and is currently being used in clinical research laboratories for both the
enrichment of CTCs and Fetal  cells.